
### [Orphanet:68334](http://www.orpha.net/ORDO/Orphanet_68334)
**Label:** Rare hemorrhagic disorder due to a constitutional coagulation factors defect

**Subclasses:** [Orphanet:331](http://www.orpha.net/ORDO/Orphanet_331) (Congenital factor XIII deficiency), [Orphanet:483](http://www.orpha.net/ORDO/Orphanet_483) (Congenital high-molecular-weight kininogen deficiency), [Orphanet:436169](http://www.orpha.net/ORDO/Orphanet_436169) (Thrombomodulin-related bleeding disorder), [Orphanet:903](http://www.orpha.net/ORDO/Orphanet_903) (Von Willebrand disease), [Orphanet:749](http://www.orpha.net/ORDO/Orphanet_749) (Congenital prekallikrein deficiency), [Orphanet:391320](http://www.orpha.net/ORDO/Orphanet_391320) (East Texas bleeding disorder), [Orphanet:329](http://www.orpha.net/ORDO/Orphanet_329) (Congenital factor XI deficiency), [Orphanet:326](http://www.orpha.net/ORDO/Orphanet_326) (Congenital factor V deficiency), [Orphanet:335](http://www.orpha.net/ORDO/Orphanet_335) (Congenital fibrinogen deficiency), [Orphanet:35909](http://www.orpha.net/ORDO/Orphanet_35909) (Combined deficiency of factor V and factor VIII), [Orphanet:79](http://www.orpha.net/ORDO/Orphanet_79) (Congenital alpha2-antiplasmin deficiency), [Orphanet:465](http://www.orpha.net/ORDO/Orphanet_465) (Congenital plasminogen activator inhibitor type 1 deficiency), 

**Corr. equiv. classes:** [Orphanet:79](http://www.orpha.net/ORDO/Orphanet_79), [Orphanet:465](http://www.orpha.net/ORDO/Orphanet_465), [Orphanet:483](http://www.orpha.net/ORDO/Orphanet_483), [Orphanet:35909](http://www.orpha.net/ORDO/Orphanet_35909), [OMIM:605913](http://purl.obolibrary.org/obo/OMIM_605913), [OMIM:228960](http://purl.obolibrary.org/obo/OMIM_228960), [OMIM:227310](http://purl.obolibrary.org/obo/OMIM_227310), [Orphanet:436169](http://www.orpha.net/ORDO/Orphanet_436169), [OMIM:613225](http://purl.obolibrary.org/obo/OMIM_613225), [OMIM:277480](http://purl.obolibrary.org/obo/OMIM_277480), [OMIM:613625](http://purl.obolibrary.org/obo/OMIM_613625), [OMIM:612416](http://purl.obolibrary.org/obo/OMIM_612416), [OMIM:613329](http://purl.obolibrary.org/obo/OMIM_613329), [Orphanet:335](http://www.orpha.net/ORDO/Orphanet_335), [Orphanet:331](http://www.orpha.net/ORDO/Orphanet_331), [OMIM:202400](http://purl.obolibrary.org/obo/OMIM_202400), [Orphanet:391320](http://www.orpha.net/ORDO/Orphanet_391320), [OMIM:262850](http://purl.obolibrary.org/obo/OMIM_262850), [OMIM:227300](http://purl.obolibrary.org/obo/OMIM_227300), [OMIM:193400](http://purl.obolibrary.org/obo/OMIM_193400), [OMIM:227400](http://purl.obolibrary.org/obo/OMIM_227400), [OMIM:314560](http://purl.obolibrary.org/obo/OMIM_314560), [OMIM:616004](http://purl.obolibrary.org/obo/OMIM_616004), [OMIM:614486](http://purl.obolibrary.org/obo/OMIM_614486), [OMIM:613235](http://purl.obolibrary.org/obo/OMIM_613235), [Orphanet:903](http://www.orpha.net/ORDO/Orphanet_903), [OMIM:613554](http://purl.obolibrary.org/obo/OMIM_613554), [Orphanet:749](http://www.orpha.net/ORDO/Orphanet_749), [OMIM:612423](http://purl.obolibrary.org/obo/OMIM_612423), [Orphanet:329](http://www.orpha.net/ORDO/Orphanet_329), [Orphanet:326](http://www.orpha.net/ORDO/Orphanet_326), 

**Class expressions from DL-Learner:**

- [HP:0010989](http://purl.obolibrary.org/obo/HP_0010989) (Abnormality of the intrinsic pathway) and (not ([HP:0003011](http://purl.obolibrary.org/obo/HP_0003011) (Abnormality of the musculature))) 52.13%
- [HP:0001892](http://purl.obolibrary.org/obo/HP_0001892) (Abnormal bleeding) and [HP:0003256](http://purl.obolibrary.org/obo/HP_0003256) (Abnormality of the coagulation cascade) 51.52%
- [HP:0010989](http://purl.obolibrary.org/obo/HP_0010989) (Abnormality of the intrinsic pathway) and (not ([HP:0012639](http://purl.obolibrary.org/obo/HP_0012639) (Abnormality of nervous system morphology))) 49.42%
- [HP:0010989](http://purl.obolibrary.org/obo/HP_0010989) (Abnormality of the intrinsic pathway) and (not ([HP:0012443](http://purl.obolibrary.org/obo/HP_0012443) (Abnormality of brain morphology))) 49.42%
- [HP:0010989](http://purl.obolibrary.org/obo/HP_0010989) (Abnormality of the intrinsic pathway) and (not ([HP:0012347](http://purl.obolibrary.org/obo/HP_0012347) (Abnormal protein N-linked glycosylation))) 49.42%
- [HP:0010989](http://purl.obolibrary.org/obo/HP_0010989) (Abnormality of the intrinsic pathway) and (not ([HP:0012346](http://purl.obolibrary.org/obo/HP_0012346) (Abnormal protein glycosylation))) 49.42%
- [HP:0010989](http://purl.obolibrary.org/obo/HP_0010989) (Abnormality of the intrinsic pathway) and (not ([HP:0012345](http://purl.obolibrary.org/obo/HP_0012345) (Abnormal glycosylation))) 49.42%
- [HP:0010989](http://purl.obolibrary.org/obo/HP_0010989) (Abnormality of the intrinsic pathway) and (not ([HP:0011013](http://purl.obolibrary.org/obo/HP_0011013) (Abnormality of carbohydrate metabolism/homeostasis))) 49.42%
- [HP:0010989](http://purl.obolibrary.org/obo/HP_0010989) (Abnormality of the intrinsic pathway) and (not ([HP:0010988](http://purl.obolibrary.org/obo/HP_0010988) (Abnormality of the extrinsic pathway))) 49.42%
- [HP:0010989](http://purl.obolibrary.org/obo/HP_0010989) (Abnormality of the intrinsic pathway) and (not ([HP:0003160](http://purl.obolibrary.org/obo/HP_0003160) (Abnormal isoelectric focusing of serum transferrin))) 49.42%
- [HP:0010989](http://purl.obolibrary.org/obo/HP_0010989) (Abnormality of the intrinsic pathway) and (not ([HP:0002011](http://purl.obolibrary.org/obo/HP_0002011) (Morphological abnormality of the central nervous system))) 49.42%
- [HP:0010989](http://purl.obolibrary.org/obo/HP_0010989) (Abnormality of the intrinsic pathway) and (not ([HP:0000707](http://purl.obolibrary.org/obo/HP_0000707) (Abnormality of the nervous system))) 49.42%
- [HP:0010989](http://purl.obolibrary.org/obo/HP_0010989) (Abnormality of the intrinsic pathway) and (not ([HP:0001976](http://purl.obolibrary.org/obo/HP_0001976) (Reduced antithrombin III activity))) 48.26%
- [HP:0010989](http://purl.obolibrary.org/obo/HP_0010989) (Abnormality of the intrinsic pathway) and (not ([HP:0011805](http://purl.obolibrary.org/obo/HP_0011805) (Abnormality of muscle morphology))) 47.20%
- [HP:0010989](http://purl.obolibrary.org/obo/HP_0010989) (Abnormality of the intrinsic pathway) and (not ([HP:0000929](http://purl.obolibrary.org/obo/HP_0000929) (Abnormality of the skull))) 47.20%


